The U.S. Food and Drug Administration issued its first denials of flavored electronic cigarettes after the agency determined the manufacturer’s products pose a greater risk to public health than any potential benefit.
Washington, D.C.— The DIVERSE Trials Act, introduced in both the House and Senate would increase diversity in clinical trials and make it easier for all cancer patients to participate in clinical trials. The bipartisan bicameral legislation, sponsored by Sens.
Today the president called on Congress to bring down patient prescription drug costs, an issue of critical importance to cancer patients. Among the provisions the president outlined was establishing an annual cap on Medicare enrollees’ out-of-pocket expenses.
Late last week the administration rescinded a proposed rule that would have tied the price of select Medicare Part B drugs to that of foreign countries. Of the 50 drugs selected for participation under the Most Favored Nation rule, 35 would have been cancer drugs.
More than two dozen patient groups and health care partners are joining forces to call for a comprehensive paid family and medical leave program, including caregiving leave.
Today the U.S. House of Representatives will begin debate on a package of funding bills for FY 2022, including funding for the National Institutes of Health (NIH) and the Centers for Disease Control and Prevention (CDC).
Washington, D.C.---Today the House Appropriations Committee will vote on a proposed FY 2022 spending bill that would increase funding for the National Institutes of Health (NIH) by $6.5 billion and include a $432 million increase for the National Cancer Institute (NCI), and $194 million for the Cancer Moonshot.
The nation’s leading patient advocacy groups are praising the U.S. Supreme Court ruling today upholding the health care law known as the Patient Protection and Affordable Care Act (ACA). The Court ruled the plaintiff states and taxpayers did not have standing to bring the suit.
Cancer patients and survivors continue to deal with the negative effects of the coronavirus pandemic on their ability to access necessary health care.
The Biden administration released its budget for FY 22 late last week. Included in the budget is an additional $9 billion in funding for the National Institutes of Health (NIH), including $6.5 for the creation of a new department within the NIH called the Advanced Research Project Agency on Health (ARPA-H).